stocksbrew
Market
Explore
Watchlist
Market
Explore
Watchlist
stocksbrew.

Analyse any US stock, then track the ones you care about.

Appearance

Product

  • Market today
  • Explore
  • Watchlist
  • Earnings
  • US stocks
  • AI agent access

Free tools

  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Use cases
  • Developer API

Company

  • About
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

stocksbrew — Verified on SubmitForBacklinksFeatured on ScrollLaunchLaunched on FazierStocksBrew - Featured on Startup FameFeatured on Wired Business
EL
ELV stock logo

Elevance Health, Inc.

Large Cap · Healthcare · Healthcare Plans

$401.36+$3.09 (+0.78%)
EL
ELV stock logo

Elevance Health, Inc.

Large Cap · Healthcare · Healthcare Plans

$401.36+$3.09 (+0.78%)

Stock analysis

$401.36+$3.09 (+0.78%)

Get the AI take on ELV

Track it to unlock the price chart, verdict and what could change it.

  • ✓Live price chart
  • ✓A clear accumulate, trim or avoid call

Free to track. No card required.

Stock Fundamentals & Key Indicators

52-week range
Low$273.71
High$436.24
Today $401.36
RSI (14)
66.1Neutral
03070100

Overall score

52/100

See the full financial picture

Open the five-year record, valuation checks and Wall Street view behind these scores.

  • ✓5 years of revenue, profit and cash flow
  • ✓Valuation and balance-sheet checks
  • ✓Business and geographic mix
  • ✓Analyst targets and recommendation trend

Free for 3 days, then $9/mo. Cancel anytime.

Analyst Rating and Sentiment

Analyst price targets

Lowest

$393

Current price

$401.36

Median target

$457

Highest

$492

LowHigh

Operating Record

Revenue

Business mix

Jun 30, 2026
Premiums82.9% · $164.8B
Product Revenue12.6% · $25.1B
Service Fees and Other4.4% · $8.8B

What's working

  • Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
  • Price / sales: You're paying a modest amount for each dollar of revenue coming in.

What to watch

  • Debt exceeds cash by $20.8B, increasing balance-sheet pressure, a warning sign.

What the market charges

Forward P/E

Favorable · 27% below avg

14.78x

Price / sales

Strong · Priced modestly against the revenue it brings in

0.43x

Price / FCF

Strong · Priced well within what its cash flow supports

13.80x

EV / EBITDA

Reasonable · Operating earnings make this price a stretch but plausible

12.93x

How efficiently it compounds

ROIC

Reasonable · A middling return on the capital it puts to work

8.5%

ROE

Middle ground · Mixed

11.1%

Debt / equity

Favorable · 0.73 - solid leverage

0.69x

Current ratio

Strong · Comfortable room to cover bills due within a year

1.52x

Peer Comparison

CompanyMkt capP/ERev growthScore
EL
ELV stock logo
ELVElevance Health, Inc.
$86.82B17.8+6.3%52
GM
GMED stock logo
GMEDGlobus Medical
$11.53B22.0+19.7%78
IN
INDV stock logo
INDVIndivior
$4.60B13.9+13.5%77
DX
DXCM stock logo
DXCMDexcom
$33.87B35.4+15.5%77
LL
LLY stock logo
LLYEli Lilly and Company
$1.11T40.1+49.6%76